PLUS THERAPEUTICS, INC. - Director's Dealing 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-01-01

Reporting Person: HENRIKSEN RONALD D (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-01	Restricted Stock Award	A	6000	—	Acquired	58092	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-01-01	Employee Stock Option	$5.19	A	15000	Acquired	2021-01-01	Common Stock (15000)	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant to Purchase Common Stock	$2.62	2014-05-12	Common Stock (38500)	38500	Direct

F1: The Restricted Stock Award ("Award") vests in full on December 31, 2011, subject to the terms of the Company's 2004 Equity Incentive Plan.

F2: The options vest 1/24 each month from date of grant, subject to the terms of the Company's 2004 Equity Incentive Plan.